Amedeo Smart

Free Medical Literature Service


 

Amedeo

Chronic Renal Failure

  Free Subscription

Articles published in
Nephrol Dial Transplant
    November 2017
  1. KONG W, Fu J, Liu N, Jiao C, et al
    Nrf2 deficiency promotes the progression from acute tubular damage to chronic renal fibrosis following unilateral ureteral obstruction.
    Nephrol Dial Transplant. 2017 Nov 6. doi: 10.1093.
    >> Share

  2. HALIMI JM, Persu A, Sarafidis PA, Burnier M, et al
    Optimizing hypertension management in renal transplantation: a call to action.
    Nephrol Dial Transplant. 2017 Nov 1. doi: 10.1093.
    >> Share

    October 2017
  3. FERRE S, Li X, Adams-Huet B, Maalouf NM, et al
    Association of serum magnesium with all-cause mortality in patients with and without chronic kidney disease in the Dallas Heart Study.
    Nephrol Dial Transplant. 2017 Oct 25. doi: 10.1093.
    >> Share

  4. FINDLAY M, MacIsaac R, MacLeod MJ, Metcalfe W, et al
    Renal replacement modality and stroke risk in end-stage renal disease-a national registry study.
    Nephrol Dial Transplant. 2017 Oct 24. doi: 10.1093.
    >> Share

  5. DELANAYE P, Paquot F, Bouquegneau A, Blocki F, et al
    Sclerostin and chronic kidney disease: the assay impacts what we (thought to) know.
    Nephrol Dial Transplant. 2017 Oct 18. doi: 10.1093.
    >> Share

  6. WILMINK T, Powers S, Hollingworth L, Stevenson T, et al
    Effect of first cannulation time and dialysis machine blood flows on survival of arteriovenous fistulas.
    Nephrol Dial Transplant. 2017 Oct 16. doi: 10.1093.
    >> Share

  7. KIM LG, Cleary F, Wheeler DC, Caplin B, et al
    How do primary care doctors in England and Wales code and manage people with chronic kidney disease? Results from the National Chronic Kidney Disease Audit.
    Nephrol Dial Transplant. 2017 Oct 16. doi: 10.1093.
    >> Share

  8. BANK JR, van der Pol P, Vreeken D, Monge-Chaubo C, et al
    Kidney injury molecule-1 staining in renal allograft biopsies 10 days after transplantation is inversely correlated with functioning proximal tubular epithelial cells.
    Nephrol Dial Transplant. 2017 Oct 16. doi: 10.1093.
    >> Share

  9. LOCATELLI F, Karaboyas A, Pisoni RL, Robinson BM, et al
    Mortality risk in patients on hemodiafiltration versus hemodialysis: a 'real-world' comparison from the DOPPS.
    Nephrol Dial Transplant. 2017 Oct 11. doi: 10.1093.
    >> Share

  10. NILSSON E, Cao Y, Lindholm B, Ohyama A, et al
    Pregnancy-associated plasma protein-A predicts survival in end-stage renal disease-confounding and modifying effects of cardiovascular disease, body composition and inflammation.
    Nephrol Dial Transplant. 2017;32:1776.
    >> Share

  11. BOS WJW, Verberne WR
    Use of a questionnaire to initiate advance care planning discussions in dialysis patients.
    Nephrol Dial Transplant. 2017;32:1599-1600.
    >> Share

  12. NGUYEN KA, Syed JS, Luciano R, Shuch B, et al
    Optimizing waiting duration for renal transplants in the setting of renal malignancy: is 2 years too long to wait?
    Nephrol Dial Transplant. 2017;32:1767-1773.
    >> Share

    September 2017
  13. LI Y, Liang M, Jiang C, Wang G, et al
    Impact of achieved blood pressure on renal function decline and first stroke in hypertensive patients with chronic kidney disease.
    Nephrol Dial Transplant. 2017 Sep 19. doi: 10.1093.
    >> Share

  14. CHESNAYE NC, van Stralen KJ, Bonthuis M, Groothoff JW, et al
    The association of donor and recipient age with graft survival in paediatric renal transplant recipients in a European Society for Paediatric Nephrology/European Renal Association-European Dialysis and Transplantation Association Registry study.
    Nephrol Dial Transplant. 2017 Sep 15. doi: 10.1093.
    >> Share

  15. ZHANG H, Chan L, Meyring-Wosten A, Campos I, et al
    Association between intradialytic central venous oxygen saturation and ultrafiltration volume in chronic hemodialysis patients.
    Nephrol Dial Transplant. 2017 Sep 12. doi: 10.1093.
    >> Share

  16. YAMAMOTO Y, Iyoda M, Tachibana S, Matsumoto K, et al
    Erlotinib attenuates the progression of chronic kidney disease in rats with remnant kidney.
    Nephrol Dial Transplant. 2017 Sep 7. doi: 10.1093.
    >> Share

  17. FUKUMA S, Shimizu S, Shintani A, Kamitani T, et al
    Development and validation of a prediction model for loss of physical function in elderly hemodialysis patients.
    Nephrol Dial Transplant. 2017 Sep 5. doi: 10.1093.
    >> Share

  18. MARKOSKA K, Pejchinovski M, Pontillo C, Zurbig P, et al
    Urinary peptide biomarker panel associated with an improvement in estimated glomerular filtration rate in chronic kidney disease patients.
    Nephrol Dial Transplant. 2017 Sep 1. doi: 10.1093.
    >> Share

    August 2017
  19. OLIVO RE, Davenport CA, Diamantidis CJ, Bhavsar NA, et al
    Obesity and synergistic risk factors for chronic kidney disease in African American adults: the Jackson Heart Study.
    Nephrol Dial Transplant. 2017 Aug 30. doi: 10.1093.
    >> Share

  20. LANG J, Katz R, Ix JH, Gutierrez OM, et al
    Association of serum albumin levels with kidney function decline and incident chronic kidney disease in elders.
    Nephrol Dial Transplant. 2017 Aug 23. doi: 10.1093.
    >> Share

  21. HAMANO H, Ikeda Y, Watanabe H, Horinouchi Y, et al
    The uremic toxin indoxyl sulfate interferes with iron metabolism by regulating hepcidin in chronic kidney disease.
    Nephrol Dial Transplant. 2017 Aug 23. doi: 10.1093.
    >> Share

  22. BRUNELLI SM, Spiegel DM, Du Mond C, Oestreicher N, et al
    Serum-to-dialysate potassium gradient and its association with short-term outcomes in hemodialysis patients.
    Nephrol Dial Transplant. 2017 Aug 19. doi: 10.1093.
    >> Share

  23. WANG IK, Lin CL, Chen HC, Lin SY, et al
    Risk of new-onset diabetes in end-stage renal disease patients undergoing dialysis: analysis from registry data of Taiwan.
    Nephrol Dial Transplant. 2017 Aug 10. doi: 10.1093.
    >> Share

  24. KARUR GR, Wald R, Goldstein MB, Wald R, et al
    Association between conversion to in-center nocturnal hemodialysis and right ventricular remodeling.
    Nephrol Dial Transplant. 2017 Aug 3. doi: 10.1093.
    >> Share

  25. VOSKAMP PWM, Rookmaaker MB, Verhaar MC, Dekker FW, et al
    Vitamin K antagonist use and mortality in dialysis patients.
    Nephrol Dial Transplant. 2017 Aug 2. doi: 10.1093.
    >> Share

  26. HAMILTON AJ, Casula A, Ben-Shlomo Y, Caskey FJ, et al
    The clinical epidemiology of young adults starting renal replacement therapy in the UK: presentation, management and survival using 15 years of UK Renal Registry data.
    Nephrol Dial Transplant. 2017;32:1434-1435.
    >> Share

    July 2017
  27. NILSSON E, Cao Y, Lindholm B, Ohyama A, et al
    Pregnancy-associated plasma protein-A predicts survival in end-stage renal disease-confounding and modifying effects of cardiovascular disease, body composition and inflammation.
    Nephrol Dial Transplant. 2017 Jul 24. doi: 10.1093.
    >> Share

  28. SNAUWAERT E, Van Biesen W, Raes A, Glorieux G, et al
    Concentrations of representative uraemic toxins in a healthy versus non-dialysis chronic kidney disease paediatric population.
    Nephrol Dial Transplant. 2017 Jul 24. doi: 10.1093.
    >> Share

  29. CAFIERO C, Gigante M, Brunetti G, Simone S, et al
    Inflammation induces osteoclast differentiation from peripheral mononuclear cells in chronic kidney disease patients: crosstalk between the immune and bone systems.
    Nephrol Dial Transplant. 2017 Jul 21. doi: 10.1093.
    >> Share

  30. TANAKA S, Ninomiya T, Katafuchi R, Masutani K, et al
    Secular trends in the incidence of end-stage renal disease and its risk factors in Japanese patients with immunoglobulin A nephropathy.
    Nephrol Dial Transplant. 2017 Jul 19. doi: 10.1093.
    >> Share

  31. MOLNAR AO, Bota SE, McArthur E, Lam NN, et al
    Risk and complications of venous thromboembolism in dialysis patients.
    Nephrol Dial Transplant. 2017 Jul 13. doi: 10.1093.
    >> Share

  32. DI IORIO BR, Marzocco S, Bellasi A, De Simone E, et al
    Nutritional therapy reduces protein carbamylation through urea lowering in chronic kidney disease.
    Nephrol Dial Transplant. 2017 Jul 11. doi: 10.1093.
    >> Share

  33. UNTERSTELLER K, Seiler-Mussler S, Mallamaci F, Fliser D, et al
    Validation of echocardiographic criteria for the clinical diagnosis of heart failure in chronic kidney disease.
    Nephrol Dial Transplant. 2017 Jul 5. doi: 10.1093.
    >> Share

  34. AL-ALI F, Hamdy AF, Hamad A, Elsayed M, et al
    Safety and efficacy of taurolidine/urokinase versus taurolidine/heparin as a tunneled catheter lock solution in hemodialysis patients: a prospective, randomized, controlled study.
    Nephrol Dial Transplant. 2017 Jul 4. doi: 10.1093.
    >> Share

  35. VAN GELDER MK, Abrahams AC, Joles JA, Kaysen GA, et al
    Albumin handling in different hemodialysis modalities.
    Nephrol Dial Transplant. 2017 Jul 3. doi: 10.1093.
    >> Share

  36. LU JL, Molnar MZ, Sumida K, Diskin CD, et al
    Association of the frequency of pre-end-stage renal disease medical care with post-end-stage renal disease mortality and hospitalization.
    Nephrol Dial Transplant. 2017 Jul 3. doi: 10.1093.
    >> Share

  37. CRITSELIS E, Vlahou A, Stel VS, Morton RL, et al
    Cost-effectiveness of screening type 2 diabetes patients for chronic kidney disease progression with the CKD273 urinary peptide classifier as compared to urinary albumin excretion.
    Nephrol Dial Transplant. 2017 Jul 3. doi: 10.1093.
    >> Share

  38. NISTOR I, De Sutter J, Drechsler C, Goldsmith D, et al
    Effect of renin-angiotensin-aldosterone system blockade in adults with diabetes mellitus and advanced chronic kidney disease not on dialysis: a systematic review and meta-analysis.
    Nephrol Dial Transplant. 2017 Jul 2. doi: 10.1093.
    >> Share

  39. CHAUVEAU P, Aparicio M, Bellizzi V, Campbell K, et al
    Mediterranean diet as the diet of choice for patients with chronic kidney disease.
    Nephrol Dial Transplant. 2017 Jul 2. doi: 10.1093.
    >> Share

  40. STENVINKEL P, Haase VH
    Inflamed fat and mitochondrial dysfunction in end-stage renal disease links to hypoxia-could curcumin be of benefit?
    Nephrol Dial Transplant. 2017;32:1263.
    >> Share

  41. SHROFF R, Wan M, Nagler EV, Bakkaloglu S, et al
    Clinical practice recommendations for treatment with active vitamin D analogues in children with chronic kidney disease Stages 2-5 and on dialysis.
    Nephrol Dial Transplant. 2017;32:1114-1127.
    >> Share

  42. SHROFF R, Wan M, Nagler EV, Bakkaloglu S, et al
    Clinical practice recommendations for native vitamin D therapy in children with chronic kidney disease Stages 2-5 and on dialysis.
    Nephrol Dial Transplant. 2017;32:1098-1113.
    >> Share

    June 2017
  43. AGARWAL R, Georgianos P
    Feeding during dialysis-risks and uncertainties.
    Nephrol Dial Transplant. 2017 Jun 19. doi: 10.1093.
    >> Share

    May 2017
  44. CHINNAPPA S, White E, Lewis N, Baldo O, et al
    Early and asymptomatic cardiac dysfunction in chronic kidney disease.
    Nephrol Dial Transplant. 2017 May 19. doi: 10.1093.
    >> Share

  45. CHO Y, Htay H, Johnson DW
    Centre effects and peritoneal dialysis-related peritonitis.
    Nephrol Dial Transplant. 2017 May 13. doi: 10.1093.
    >> Share

  46. BECHADE C, Guillouet S, Verger C, Ficheux M, et al
    Centre characteristics associated with the risk of peritonitis in peritoneal dialysis: a hierarchical modelling approach based on the data of the French Language Peritoneal Dialysis Registry.
    Nephrol Dial Transplant. 2017 May 2. doi: 10.1093.
    >> Share

  47. TANGRI N, Ferguson T, Komenda P
    Pro: Risk scores for chronic kidney disease progression are robust, powerful and ready for implementation.
    Nephrol Dial Transplant. 2017;32:748-751.
    >> Share

    April 2017
  48. STENVINKEL P, Haase VH
    Inflamed fat and mitochondrial dysfunction in end-stage renal disease links to hypoxia-could curcumin be of benefit?
    Nephrol Dial Transplant. 2017 Apr 28. doi: 10.1093.
    >> Share

  49. CHOU JA, Streja E, Nguyen DV, Rhee CM, et al
    Intradialytic hypotension, blood pressure changes and mortality risk in incident hemodialysis patients.
    Nephrol Dial Transplant. 2017 Apr 21. doi: 10.1093.
    >> Share

  50. VANHOLDER R, Gryp T, Glorieux G
    Urea and chronic kidney disease: the comeback of the century? (in uraemia research).
    Nephrol Dial Transplant. 2017 Apr 12. doi: 10.1093.
    >> Share

  51. VAN DER PLAS WY, Dulfer RR, Engelsman AF, Vogt L, et al
    Effect of parathyroidectomy and cinacalcet on quality of life in patients with end-stage renal disease-related hyperparathyroidism: a systematic review.
    Nephrol Dial Transplant. 2017 Apr 10. doi: 10.1093.
    >> Share

  52. DE BROE ME, Gharbi MB, Zamd M, Elseviers M, et al
    Why overestimate or underestimate chronic kidney disease when correct estimation is possible?
    Nephrol Dial Transplant. 2017;32.
    >> Share

  53. GUTHOFF M, Wagner R, Vosseler D, Peter A, et al
    Impact of end-stage renal disease on glucose metabolism-a matched cohort analysis.
    Nephrol Dial Transplant. 2017;32:670-676.
    >> Share

  54. NDLOVU KC, Sibanda W, Assounga A
    Detection of human immunodeficiency virus-1 ribonucleic acid in the peritoneal effluent of renal failure patients on highly active antiretroviral therapy.
    Nephrol Dial Transplant. 2017;32:714-721.
    >> Share

  55. BIRNIE K, Caskey F, Ben-Shlomo Y, Sterne JA, et al
    Erythropoiesis-stimulating agent dosing, haemoglobin and ferritin levels in UK haemodialysis patients 2005-13.
    Nephrol Dial Transplant. 2017;32:692-698.
    >> Share

    March 2017
  56. NAZZAL L, Roberts J, Singh P, Jhawar S, et al
    Microbiome perturbation by oral vancomycin reduces plasma concentration of two gut-derived uremic solutes, indoxyl sulfate and p-cresyl sulfate, in end-stage renal disease.
    Nephrol Dial Transplant. 2017 Mar 31. doi: 10.1093.
    >> Share

  57. BURLACU A, Genovesi S, Ortiz A, Kanbay M, et al
    The quest for equilibrium: exploring the thin red line between bleeding and ischaemic risks in the management of acute coronary syndromes in chronic kidney disease patients.
    Nephrol Dial Transplant. 2017 Mar 27. doi: 10.1093.
    >> Share

  58. RODRIGUES J, Cuppari L, Campbell KL, Avesani CM, et al
    Nutritional assessment of elderly patients on dialysis: pitfalls and potentials for practice.
    Nephrol Dial Transplant. 2017 Mar 22. doi: 10.1093.
    >> Share

  59. OBI Y, Kalantar-Zadeh K, Streja E, Daugirdas JT, et al
    Prediction equation for calculating residual kidney urea clearance using urine collections for different hemodialysis treatment frequencies and interdialytic intervals.
    Nephrol Dial Transplant. 2017 Mar 15. doi: 10.1093.
    >> Share

  60. SARAFIDIS PA, Persu A, Agarwal R, Burnier M, et al
    Hypertension in dialysis patients: a consensus document by the European Renal and Cardiovascular Medicine (EURECA-m) working group of the European Renal Association-European Dialysis and Transplant Association (ERA-EDTA) and the Hypertension and the K
    Nephrol Dial Transplant. 2017 Mar 13. doi: 10.1093.
    >> Share

  61. VAN GELOVEN N, le Cessie S, Dekker FW, Putter H, et al
    Transplant as a competing risk in the analysis of dialysis patients.
    Nephrol Dial Transplant. 2017 Mar 3. doi: 10.1093.
    >> Share

  62. CAMPBELL GA, Patrie JT, Gaylinn BD, Thorner MO, et al
    Oral ghrelin receptor agonist MK-0677 increases serum insulin-like growth factor 1 in hemodialysis patients: a randomized blinded study.
    Nephrol Dial Transplant. 2017 Mar 3. doi: 10.1093.
    >> Share

  63. ZHOU Y, Hellberg M, Svensson P, Hoglund P, et al
    Sarcopenia and relationships between muscle mass, measured glomerular filtration rate and physical function in patients with chronic kidney disease stages 3-5.
    Nephrol Dial Transplant. 2017 Mar 1. doi: 10.1093.
    >> Share

  64. BOLIGNANO D, Zoccali C
    Non-proteinuric rather than proteinuric renal diseases are the leading cause of end-stage kidney disease.
    Nephrol Dial Transplant. 2017 Mar 1. doi: 10.1093.
    >> Share

  65. CHEN DQ, Chen H, Chen L, Vaziri ND, et al
    The link between phenotype and fatty acid metabolism in advanced chronic kidney disease.
    Nephrol Dial Transplant. 2017 Mar 1. doi: 10.1093.
    >> Share

  66. NUBE MJ, Peters SAE, Blankestijn PJ, Canaud B, et al
    Mortality reduction by post-dilution online-haemodiafiltration: a cause-specific analysis.
    Nephrol Dial Transplant. 2017;32:548-555.
    >> Share

  67. MARANO M, Marano S, Gennari FJ
    Beyond bicarbonate: complete acid-base assessment in patients receiving intermittent hemodialysis.
    Nephrol Dial Transplant. 2017;32:528-533.
    >> Share

  68. YOKOYAMA K, Kurita N, Fukuma S, Akizawa T, et al
    Frequent monitoring of mineral metabolism in hemodialysis patients with secondary hyperparathyroidism: associations with achievement of treatment goals and with adjustments in therapy.
    Nephrol Dial Transplant. 2017;32:534-541.
    >> Share

    February 2017
  69. HAZELBAG CM, Peters SA, Blankestijn PJ, Bots ML, et al
    The importance of considering competing treatment affecting prognosis in the evaluation of therapy in trials: the example of renal transplantation in hemodialysis trials.
    Nephrol Dial Transplant. 2017 Feb 27. doi: 10.1093.
    >> Share

  70. XIA J, Wang L, Ma Z, Zhong L, et al
    Cigarette smoking and chronic kidney disease in the general population: a systematic review and meta-analysis of prospective cohort studies.
    Nephrol Dial Transplant. 2017 Feb 27. doi: 10.1093.
    >> Share

  71. FLOEGE J, Covic AC, Ketteler M, Mann J, et al
    One-year efficacy and safety of the iron-based phosphate binder sucroferric oxyhydroxide in patients on peritoneal dialysis.
    Nephrol Dial Transplant. 2017 Feb 23. doi: 10.1093.
    >> Share

  72. HAMILTON AJ, Casula A, Ben-Shlomo Y, Caskey FJ, et al
    The clinical epidemiology of young adults starting renal replacement therapy in the UK: presentation, management and survival using 15 years of UK Renal Registry data.
    Nephrol Dial Transplant. 2017 Feb 23. doi: 10.1093.
    >> Share

  73. METHVEN S, Gasparini A, Carrero JJ, Caskey FJ, et al
    Routinely measured iohexol glomerular filtration rate versus creatinine-based estimated glomerular filtration rate as predictors of mortality in patients with advanced chronic kidney disease: a Swedish Chronic Kidney Disease Registry cohort study.
    Nephrol Dial Transplant. 2017 Feb 23. doi: 10.1093.
    >> Share

  74. ZECHER D, Bach C, Staudner C, Boger CA, et al
    Characteristics of donor-specific anti-HLA antibodies and outcome in renal transplant patients treated with a standardized induction regimen.
    Nephrol Dial Transplant. 2017 Feb 18. doi: 10.1093.
    >> Share

  75. HU JR, Coresh J
    The public health dimension of chronic kidney disease: what we have learnt over the past decade.
    Nephrol Dial Transplant. 2017 Feb 16. doi: 10.1093.
    >> Share

  76. CHONG K, Unruh M
    Why does quality of life remain an under-investigated issue in chronic kidney disease and why is it rarely set as an outcome measure in trials in this population?
    Nephrol Dial Transplant. 2017 Feb 16. doi: 10.1093.
    >> Share

  77. VAN LAECKE S, Van Biesen W
    Smoking and chronic kidney disease: seeing the signs through the smoke?
    Nephrol Dial Transplant. 2017 Feb 16. doi: 10.1093.
    >> Share

  78. STEL VS, Bruck K, Fraser S, Zoccali C, et al
    International differences in chronic kidney disease prevalence: a key public health and epidemiologic research issue.
    Nephrol Dial Transplant. 2017 Feb 16. doi: 10.1093.
    >> Share

  79. KABORE R, Haller MC, Harambat J, Heinze G, et al
    Risk prediction models for graft failure in kidney transplantation: a systematic review.
    Nephrol Dial Transplant. 2017 Feb 16. doi: 10.1093.
    >> Share

  80. OBI Y, Kalantar-Zadeh K, Streja E, Rhee CM, et al
    Seasonal variations in transition, mortality and kidney transplantation among patients with end-stage renal disease in the USA.
    Nephrol Dial Transplant. 2017 Feb 11. doi: 10.1093.
    >> Share

  81. KALANTAR-ZADEH K, Kovesdy CP, Streja E, Rhee CM, et al
    Transition of care from pre-dialysis prelude to renal replacement therapy: the blueprints of emerging research in advanced chronic kidney disease.
    Nephrol Dial Transplant. 2017 Feb 11. doi: 10.1093.
    >> Share

  82. PORT FK, Morgenstern H, Bieber BA, Karaboyas A, et al
    Understanding associations of hemodialysis practices with clinical and patient-reported outcomes: examples from the DOPPS.
    Nephrol Dial Transplant. 2017 Feb 11. doi: 10.1093.
    >> Share

  83. ASGHARI G, Yuzbashian E, Mirmiran P, Azizi F, et al
    The association between Dietary Approaches to Stop Hypertension and incidence of chronic kidney disease in adults: the Tehran Lipid and Glucose Study.
    Nephrol Dial Transplant. 2017 Feb 11. doi: 10.1093.
    >> Share

  84. KOVESDY CP, Kalantar-Zadeh K
    DASH-ing toward improved renal outcomes: when healthy nutrition prevents incident chronic kidney disease.
    Nephrol Dial Transplant. 2017 Feb 11. doi: 10.1093.
    >> Share

  85. IWAGAMI M, Tomlinson LA, Mansfield KE, Casula A, et al
    Validity of estimated prevalence of decreased kidney function and renal replacement therapy from primary care electronic health records compared with national survey and registry data in the United Kingdom.
    Nephrol Dial Transplant. 2017 Feb 11. doi: 10.1093.
    >> Share

  86. JAGER KJ, Fraser SD
    The ascending rank of chronic kidney disease in the global burden of disease study.
    Nephrol Dial Transplant. 2017 Feb 11. doi: 10.1093.
    >> Share

  87. KOVESDY CP
    Hypertension in chronic kidney disease after the Systolic Blood Pressure Intervention Trial: targets, treatment and current uncertainties.
    Nephrol Dial Transplant. 2017 Feb 11. doi: 10.1093.
    >> Share

  88. TOMLINSON LA, Fogarty DG, Douglas I, Nitsch D, et al
    Pharmacoepidemiology for nephrologists: do proton pump inhibitors cause chronic kidney disease?
    Nephrol Dial Transplant. 2017 Feb 11. doi: 10.1093.
    >> Share

  89. TJADEN LA, Jager KJ, Bonthuis M, Kuehni CE, et al
    Racial variation in cardiovascular disease risk factors among European children on renal replacement therapy-results from the European Society of Paediatric Nephrology/European Renal Association - European Dialysis and Transplant Association Registry.
    Nephrol Dial Transplant. 2017 Feb 1. doi: 10.1093.
    >> Share

  90. ROBINSKI M, Mau W, Wienke A, Girndt M, et al
    The Choice of Renal Replacement Therapy (CORETH) project: dialysis patients' psychosocial characteristics and treatment satisfaction.
    Nephrol Dial Transplant. 2017;32:315-324.
    >> Share

  91. WONG B, Venturato L, Oliver MJ, Quinn RR, et al
    Selection of peritoneal dialysis among older eligible patients with end-stage renal disease.
    Nephrol Dial Transplant. 2017;32:384-392.
    >> Share

  92. KIM T, Rhee CM, Streja E, Obi Y, et al
    Longitudinal trends in serum ferritin levels and associated factors in a national incident hemodialysis cohort.
    Nephrol Dial Transplant. 2017;32:370-377.
    >> Share

  93. MOISEEV S, Novikov P, Jayne D, Mukhin N, et al
    End-stage renal disease in ANCA-associated vasculitis.
    Nephrol Dial Transplant. 2017;32:248-253.
    >> Share

  94. FICHEUX A, Gayrard N, Duranton F, Guzman C, et al
    A reliable method to assess the water permeability of a dialysis system: the global ultrafiltration coefficient.
    Nephrol Dial Transplant. 2017;32:364-370.
    >> Share

  95. PARK JI, Park JT, Kim YL, Kang SW, et al
    Comparison of outcomes between the incremental and thrice-weekly initiation of hemodialysis: a propensity-matched study of a prospective cohort in Korea.
    Nephrol Dial Transplant. 2017;32:355-363.
    >> Share

  96. TORRES RV, Elias MF, Seliger S, Davey A, et al
    Risk for cognitive impairment across 22 measures of cognitive ability in early-stage chronic kidney disease.
    Nephrol Dial Transplant. 2017;32:299-306.
    >> Share

  97. SEKULA P, Li Y, Stanescu HC, Wuttke M, et al
    Genetic risk variants for membranous nephropathy: extension of and association with other chronic kidney disease aetiologies.
    Nephrol Dial Transplant. 2017;32:325-332.
    >> Share

  98. TROJANOWICZ B, Ulrich C, Kohler F, Bode V, et al
    Monocytic angiotensin-converting enzyme 2 relates to atherosclerosis in patients with chronic kidney disease.
    Nephrol Dial Transplant. 2017;32:287-298.
    >> Share

  99. FLISER D, Dellanna F, Koch M, Wiggenhauser A, et al
    Early low-dose erythropoiesis-stimulating agent therapy and progression of moderate chronic kidney disease: a randomized, placebo-controlled trial.
    Nephrol Dial Transplant. 2017;32:279-287.
    >> Share

    January 2017
  100. HSIEH MY, Chen TY, Lin L, Chuang SY, et al
    Deficiency of circulating progenitor cells associated with vascular thrombosis of hemodialysis patients.
    Nephrol Dial Transplant. 2017 Jan 17. doi: 10.1093.
    >> Share

  101. KIM LG, Caplin B, Cleary F, Hull SA, et al
    Accounting for overdispersion when determining primary care outliers for the identification of chronic kidney disease: learning from the National Chronic Kidney Disease Audit.
    Nephrol Dial Transplant. 2017 Jan 17. doi: 10.1093.
    >> Share

  102. GALBRAITH L, Jacobs C, Hemmelgarn BR, Donald M, et al
    Chronic disease management interventions for people with chronic kidney disease in primary care: a systematic review and meta-analysis.
    Nephrol Dial Transplant. 2017 Jan 16. pii: gfw359. doi: 10.1093.
    >> Share

  103. CHEN HJ, Wang JJ, Tsay WI, Her SH, et al
    Epidemiology and outcome of acute pancreatitis in end-stage renal disease dialysis patients: a 10-year national cohort study.
    Nephrol Dial Transplant. 2017 Jan 14. pii: gfw400. doi: 10.1093.
    >> Share

  104. MAFHAM MM, Staplin N, Emberson J, Haynes R, et al
    Prognostic utility of estimated albumin excretion rate in chronic kidney disease: results from the Study of Heart and Renal Protection.
    Nephrol Dial Transplant. 2017 Jan 14. pii: gfw396. doi: 10.1093.
    >> Share

  105. IVORY SE, Polkinghorne KR, Khandakar Y, Kasza J, et al
    Predicting 6-month mortality risk of patients commencing dialysis treatment for end-stage kidney disease.
    Nephrol Dial Transplant. 2017 Jan 10. pii: gfw383. doi: 10.1093.
    >> Share

  106. SUMIDA K, Molnar MZ, Potukuchi PK, Thomas F, et al
    Prognostic significance of pre-end-stage renal disease serum alkaline phosphatase for post-end-stage renal disease mortality in late-stage chronic kidney disease patients transitioning to dialysis.
    Nephrol Dial Transplant. 2017 Jan 7. pii: gfw412. doi: 10.1093.
    >> Share

  107. PARK C, Obi Y, Streja E, Rhee CM, et al
    Serum uric acid, protein intake and mortality in hemodialysis patients.
    Nephrol Dial Transplant. 2017 Jan 7. pii: gfw419. doi: 10.1093.
    >> Share

  108. COUCHOUD C, Dantony E, Elsensohn MH, Villar E, et al
    Restricted mean survival time over 15 years for patients starting renal replacement therapy.
    Nephrol Dial Transplant. 2017 Jan 5. pii: gfw386. doi: 10.1093.
    >> Share

  109. FARRINGTON K, Covic A, Nistor I, Aucella F, et al
    Clinical Practice Guideline on management of older patients with chronic kidney disease stage 3b or higher (eGFR<45 mL/min/1.73 m2): a summary document from the European Renal Best Practice Group.
    Nephrol Dial Transplant. 2017;32:9-16.
    >> Share

  110. CASINO FG, Basile C
    The variable target model: a paradigm shift in the incremental haemodialysis prescription.
    Nephrol Dial Transplant. 2017;32:182-190.
    >> Share

  111. BRANDENBURG VM, Kramann R, Rothe H, Kaesler N, et al
    Calcific uraemic arteriolopathy (calciphylaxis): data from a large nationwide registry.
    Nephrol Dial Transplant. 2017;32:126-132.
    >> Share

  112. SEGALL L, Nistor I, Van Biesen W, Brown EA, et al
    Dialysis modality choice in elderly patients with end-stage renal disease: a narrative review of the available evidence.
    Nephrol Dial Transplant. 2017;32:41-49.
    >> Share

    December 2016
  113. VAN DEN BRAND JA, Pippias M, Stel VS, Caskey FJ, et al
    Lifetime risk of renal replacement therapy in Europe: a population-based study using data from the ERA-EDTA Registry.
    Nephrol Dial Transplant. 2016 Dec 28. pii: gfw392. doi: 10.1093.
    >> Share

  114. PICHLER G, Haller MC, Kainz A, Wolf M, et al
    Prognostic value of bone- and vascular-derived molecular biomarkers in hemodialysis and renal transplant patients: a systematic review and meta-analysis.
    Nephrol Dial Transplant. 2016 Dec 26. pii: gfw387. doi: 10.1093.
    >> Share

  115. LIN CH, Hung PH, Hu HY, Chen YJ, et al
    Infection-related hospitalization and risk of end-stage renal disease in patients with systemic lupus erythematosus: a nationwide population-based study.
    Nephrol Dial Transplant. 2016 Dec 22. pii: gfw407. doi: 10.1093.
    >> Share

    November 2016
  116. FARRINGTON K, Covic A, Aucella F, Clyne N, et al
    Clinical Practice Guideline on management of older patients with chronic kidney disease stage 3b or higher (eGFR <45 mL/min/1.73 m2).
    Nephrol Dial Transplant. 2016;31.
    >> Share

  117. WITHAM MD, Lamb EJ
    Should chronic metabolic acidosis be treated in older people with chronic kidney disease?
    Nephrol Dial Transplant. 2016;31:1796-1802.
    >> Share

    October 2016
  118. CHANG TI, Ngo V, Streja E, Chou JA, et al
    Association of body weight changes with mortality in incident hemodialysis patients.
    Nephrol Dial Transplant. 2016.
    >> Share

  119. PEFANIS A, Botlero R, Langham RG, Nelson CL, et al
    eMAP:CKD: electronic diagnosis and management assistance to primary care in chronic kidney disease.
    Nephrol Dial Transplant. 2016.
    >> Share

  120. WONG B, Venturato L, Oliver MJ, Quinn RR, et al
    Selection of peritoneal dialysis among older eligible patients with end-stage renal disease.
    Nephrol Dial Transplant. 2016.
    >> Share

  121. STREJA E, Kalantar-Zadeh K, Molnar MZ, Landman J, et al
    Radical versus partial nephrectomy, chronic kidney disease progression and mortality in US veterans.
    Nephrol Dial Transplant. 2016.
    >> Share

  122. MILANI B, Ansaloni A, Sousa-Guimaraes S, Vakilzadeh N, et al
    Reduction of cortical oxygenation in chronic kidney disease: evidence obtained with a new analysis method of blood oxygenation level-dependent magnetic resonance imaging.
    Nephrol Dial Transplant. 2016.
    >> Share

  123. GILL S, Jun M, Ravani P
    Atrial fibrillation and chronic kidney disease: struggling through thick and thin.
    Nephrol Dial Transplant. 2016.
    >> Share

  124. DELLO STROLOGO L, Murer L, Guzzo I, Morolli F, et al
    Renal transplantation in sensitized children and young adults: a nationwide approach.
    Nephrol Dial Transplant. 2016.
    >> Share

  125. DAUGIRDAS JT
    A two-pool kinetic model predicts phosphate concentrations during and shortly following a conventional (three times weekly) hemodialysis session.
    Nephrol Dial Transplant. 2016.
    >> Share

  126. GASPARINI A, Evans M, Coresh J, Grams ME, et al
    Prevalence and recognition of chronic kidney disease in Stockholm healthcare.
    Nephrol Dial Transplant. 2016.
    >> Share

  127. SIWY J, Zurbig P, Argiles A, Beige J, et al
    Noninvasive diagnosis of chronic kidney diseases using urinary proteome analysis.
    Nephrol Dial Transplant. 2016.
    >> Share

    September 2016
  128. HENSEN LC, Delgado V, van Wijngaarden SE, Leung M, et al
    Echocardiographic associates of atrial fibrillation in end-stage renal disease.
    Nephrol Dial Transplant. 2016.
    >> Share

  129. PARK JI, Park JT, Kim YL, Kang SW, et al
    Comparison of outcomes between the incremental and thrice-weekly initiation of hemodialysis: a propensity-matched study of a prospective cohort in Korea.
    Nephrol Dial Transplant. 2016.
    >> Share

  130. EVANS M, Carrero JJ, Bellocco R, Barany P, et al
    Initiation of erythropoiesis-stimulating agents and outcomes: a nationwide observational cohort study in anaemic chronic kidney disease patients.
    Nephrol Dial Transplant. 2016.
    >> Share

  131. GARGANI L, Sicari R, Raciti M, Serasini L, et al
    Efficacy of a remote web-based lung ultrasound training for nephrologists and cardiologists: a LUST trial sub-project.
    Nephrol Dial Transplant. 2016.
    >> Share

  132. SHAFI T
    CKD to ESRD transition: does assessment of kidney function matter?
    Nephrol Dial Transplant. 2016.
    >> Share

  133. RHEE CM, You AS, Koontz Parsons T, Tortorici AR, et al
    Effect of high-protein meals during hemodialysis combined with lanthanum carbonate in hypoalbuminemic dialysis patients: findings from the FrEDI randomized controlled trial.
    Nephrol Dial Transplant. 2016.
    >> Share

  134. AGARWAL R
    Albuminuria and masked uncontrolled hypertension in chronic kidney disease.
    Nephrol Dial Transplant. 2016.
    >> Share

  135. HABBOUS S, Przech S, Acedillo R, Sarma S, et al
    The efficacy and safety of sevelamer and lanthanum versus calcium-containing and iron-based binders in treating hyperphosphatemia in patients with chronic kidney disease: a systematic review and meta-analysis.
    Nephrol Dial Transplant. 2016.
    >> Share


  136. Randomized multicentre pilot study of sacubitril/valsartan versus irbesartan in patients with chronic kidney disease: United Kingdom Heart and Renal Protection (HARP)- III-rationale, trial design and baseline data.
    Nephrol Dial Transplant. 2016.
    >> Share

  137. TOKOROYAMA T, Ando M, Setoguchi K, Tsuchiya K, et al
    Prevalence, incidence and prognosis of chronic kidney disease classified according to current guidelines: a large retrospective cohort study of rheumatoid arthritis patients.
    Nephrol Dial Transplant. 2016.
    >> Share

  138. LIU CH, Yeh MK, Weng SC, Bai MY, et al
    Suicide and chronic kidney disease: a case-control study.
    Nephrol Dial Transplant. 2016.
    >> Share

  139. MICHELS WM, Jaar BG, Ephraim PL, Liu Y, et al
    Intravenous iron administration strategies and anemia management in hemodialysis patients.
    Nephrol Dial Transplant. 2016.
    >> Share

  140. KIRSCH AH, Lyko R, Nilsson LG, Beck W, et al
    Performance of hemodialysis with novel medium cut-off dialyzers.
    Nephrol Dial Transplant. 2016.
    >> Share

  141. ENGBERG H, Wehberg S, Bistrup C, Heaf J, et al
    Cancer risk and mortality after kidney transplantation: a population-based study on differences between Danish centres using standard immunosuppression with and without glucocorticoids.
    Nephrol Dial Transplant. 2016.
    >> Share

    August 2016
  142. LADIN K, Lin N, Hahn E, Zhang G, et al
    Engagement in decision-making and patient satisfaction: a qualitative study of older patients' perceptions of dialysis initiation and modality decisions.
    Nephrol Dial Transplant. 2016.
    >> Share

  143. ABAJO M, Betriu A, Arroyo D, Gracia M, et al
    Mineral metabolism factors predict accelerated progression of common carotid intima-media thickness in chronic kidney disease: the NEFRONA study.
    Nephrol Dial Transplant. 2016.
    >> Share

  144. WANG IK, Lin KH, Lin SY, Lin CL, et al
    Permanent cardiac pacing in patients with end-stage renal disease undergoing dialysis.
    Nephrol Dial Transplant. 2016.
    >> Share

  145. SCHULTHEISS UT, Daya N, Grams ME, Seufert J, et al
    Thyroid function, reduced kidney function and incident chronic kidney disease in a community-based population: the Atherosclerosis Risk in Communities study.
    Nephrol Dial Transplant. 2016.
    >> Share

  146. VAN CRAENENBROECK AH, Van Craenenbroeck EM, Van Ackeren K, Hoymans VY, et al
    Impaired vascular function contributes to exercise intolerance in chronic kidney disease.
    Nephrol Dial Transplant. 2016.
    >> Share

  147. MARTIN-ALEMANY G, Valdez-Ortiz R, Olvera-Soto G, Gomez-Guerrero I, et al
    The effects of resistance exercise and oral nutritional supplementation during hemodialysis on indicators of nutritional status and quality of life.
    Nephrol Dial Transplant. 2016.
    >> Share

  148. RODENBECK SD, Zarse CA, McKenney-Drake ML, Bruning RS, et al
    Intracellular calcium increases in vascular smooth muscle cells with progression of chronic kidney disease in a rat model.
    Nephrol Dial Transplant. 2016.
    >> Share

  149. MCMAHON LP
    Exercise limitation in chronic kidney disease: deep seas and new shores.
    Nephrol Dial Transplant. 2016.
    >> Share

    July 2016
  150. AGARWAL R
    Arterial stiffness and its relationship to clinic and ambulatory blood pressure: a longitudinal study in non-dialysis chronic kidney disease.
    Nephrol Dial Transplant. 2016.
    >> Share

  151. WANG IK, Shen TC, Muo CH, Yen TH, et al
    Risk of pulmonary embolism in patients with end-stage renal disease receiving long-term dialysis.
    Nephrol Dial Transplant. 2016.
    >> Share

  152. KAMBUR TR, Das M, Agarwal R
    The natural history of symptomatic cardiac conduction-system disease in end-stage renal disease.
    Nephrol Dial Transplant. 2016.
    >> Share

  153. RENE E, Lazrak HH, Laurin LP, Elftouh N, et al
    Association of erythropoiesis-stimulating agents and the incidence risk of cancer diagnosis among chronic dialysis patients: a nested case-control study.
    Nephrol Dial Transplant. 2016.
    >> Share

  154. ZICKLER D, Willy K, Girndt M, Fiedler R, et al
    High cut-off dialysis in chronic haemodialysis patients reduces serum procalcific activity.
    Nephrol Dial Transplant. 2016.
    >> Share

  155. AGARWAL R, Pappas MK
    Delayed systolic blood pressure recovery following exercise as a mechanism of masked uncontrolled hypertension in chronic kidney disease.
    Nephrol Dial Transplant. 2016.
    >> Share

  156. KALANTAR-ZADEH K
    Moderator's view: Higher serum bicarbonate in dialysis patients is protective.
    Nephrol Dial Transplant. 2016.
    >> Share

  157. CHAUVEAU P, Rigothier C, Combe C, Misra M, et al
    Con: Higher serum bicarbonate in dialysis patients is protective.
    Nephrol Dial Transplant. 2016.
    >> Share

  158. MISRA M, Combe C
    Pro: Higher serum bicarbonate in dialysis patients is protective.
    Nephrol Dial Transplant. 2016.
    >> Share

  159. WAKASUGI M, Kazama JJ, Narita I
    Mortality trends among Japanese dialysis patients, 1988-2013: a joinpoint regression analysis.
    Nephrol Dial Transplant. 2016.
    >> Share

  160. PEJCHINOVSKI M, Siwy J, Metzger J, Dakna M, et al
    Urine peptidome analysis predicts risk of end-stage renal disease and reveals proteolytic pathways involved in autosomal dominant polycystic kidney disease progression.
    Nephrol Dial Transplant. 2016.
    >> Share

  161. HALLECK F, Khadzhynov D, Liefeldt L, Schrezenmeier E, et al
    Immunologic outcome in elderly kidney transplant recipients: is it time for HLA-DR matching?
    Nephrol Dial Transplant. 2016.
    >> Share

    June 2016
  162. RAVEL VA, Streja E, Mehrotra R, Sim JJ, et al
    Serum sodium and mortality in a national peritoneal dialysis cohort.
    Nephrol Dial Transplant. 2016.
    >> Share

  163. MCMAHON GM, Hwang SJ, Fox CS
    Residual lifetime risk of chronic kidney disease.
    Nephrol Dial Transplant. 2016.
    >> Share

  164. COVIC AC, Floege J, Ketteler M, Sprague SM, et al
    Iron-related parameters in dialysis patients treated with sucroferric oxyhydroxide.
    Nephrol Dial Transplant. 2016.
    >> Share

  165. LIPS L, de Roij van Zuijdewijn CL, Ter Wee PM, Bots ML, et al
    Serum sclerostin: relation with mortality and impact of hemodiafiltration.
    Nephrol Dial Transplant. 2016.
    >> Share

  166. RAMSPEK CL, Nacak H, van Diepen M, van Buren M, et al
    Pre-dialysis decline of measured glomerular filtration rate but not serum creatinine-based estimated glomerular filtration rate is a risk factor for mortality on dialysis.
    Nephrol Dial Transplant. 2016.
    >> Share

  167. HUBER M, Kemmner S, Renders L, Heemann U, et al
    Should belatacept be the centrepiece of renal transplantation?
    Nephrol Dial Transplant. 2016.
    >> Share

  168. TAMEZ H
    African Americans with left ventricular hypertrophy and chronic kidney disease: what should we do?
    Nephrol Dial Transplant. 2016.
    >> Share

  169. PERL J, Karaboyas A, Morgenstern H, Sen A, et al
    Association between changes in quality of life and mortality in hemodialysis patients: results from the DOPPS.
    Nephrol Dial Transplant. 2016.
    >> Share

  170. WAIKAR SS, Sabbisetti V, Arnlov J, Carlsson AC, et al
    Relationship of proximal tubular injury to chronic kidney disease as assessed by urinary kidney injury molecule-1 in five cohort studies.
    Nephrol Dial Transplant. 2016.
    >> Share

  171. ELLIOTT MJ, Gil S, Hemmelgarn BR, Manns BJ, et al
    A scoping review of adult chronic kidney disease clinical pathways for primary care.
    Nephrol Dial Transplant. 2016.
    >> Share

  172. DEY V, Farrah TE, Traynor JP, Spalding EM, et al
    Symptomatic fracture risk in the renal replacement therapy population.
    Nephrol Dial Transplant. 2016.
    >> Share

  173. FRANCESCHINI N, Deng Y, Flessner MF, Eckfeldt JH, et al
    Smoking patterns and chronic kidney disease in US Hispanics: the Hispanics Community Health Study/the Study of Latinos.
    Nephrol Dial Transplant. 2016.
    >> Share

  174. STANIFER JW, Muiru A, Jafar TH, Patel UD, et al
    Chronic kidney disease in low- and middle-income countries.
    Nephrol Dial Transplant. 2016;31:868-74.
    >> Share

    May 2016
  175. SUMIDA K, Molnar MZ, Potukuchi PK, Thomas F, et al
    Association between vascular access creation and deceleration of estimated glomerular filtration rate decline in late-stage chronic kidney disease patients transitioning to end-stage renal disease.
    Nephrol Dial Transplant. 2016.
    >> Share

  176. TANAKA S, Ninomiya T, Taniguchi M, Fujisaki K, et al
    Comparison of oral versus intravenous vitamin D receptor activator in reducing infection-related mortality in hemodialysis patients: the Q-Cohort Study.
    Nephrol Dial Transplant. 2016.
    >> Share

  177. BRAMHAM K
    Dialysis and pregnancy: no longer the impossible.
    Nephrol Dial Transplant. 2016.
    >> Share

  178. PLANTINGA L, Gander JC
    Intermittent smoking and chronic kidney disease.
    Nephrol Dial Transplant. 2016.
    >> Share

  179. WESTER M, Gerritsen KG, Simonis F, Boer WH, et al
    A regenerable potassium and phosphate sorbent system to enhance dialysis efficacy and device portability: a study in awake goats.
    Nephrol Dial Transplant. 2016.
    >> Share

  180. SNAEDAL S, Qureshi AR, Lund SH, Germanis G, et al
    Dialysis modality and nutritional status are associated with variability of inflammatory markers.
    Nephrol Dial Transplant. 2016.
    >> Share

  181. HAVERKAMP GL, Loosman WL, Franssen CF, Kema IP, et al
    The role of tryptophan degradation in the association between inflammatory markers and depressive symptoms in chronic dialysis patients.
    Nephrol Dial Transplant. 2016.
    >> Share

  182. TROJANOWICZ B, Ulrich C, Kohler F, Bode V, et al
    Monocytic angiotensin-converting enzyme 2 relates to atherosclerosis in patients with chronic kidney disease.
    Nephrol Dial Transplant. 2016.
    >> Share

  183. HUANG H, Jolly SE, Airy M, Arrigain S, et al
    Associations of dysnatremias with mortality in chronic kidney disease.
    Nephrol Dial Transplant. 2016.
    >> Share

  184. JOHANSSON L, Fouque D, Bellizzi V, Chauveau P, et al
    As we grow old: nutritional considerations for older patients on dialysis.
    Nephrol Dial Transplant. 2016.
    >> Share

  185. KERR M, Matthews B, Medcalf JF, O'Donoghue D, et al
    End-of-life care for people with chronic kidney disease: cause of death, place of death and hospital costs.
    Nephrol Dial Transplant. 2016.
    >> Share

  186. ZHONG H, Zhang W, Qin M, Gou Z, et al
    Validation of cystatin C-based equations for evaluating residual renal function in patients on continuous ambulatory peritoneal dialysis.
    Nephrol Dial Transplant. 2016.
    >> Share

  187. KRANE V, Wanner C
    Should we aim for oral health to improve outcomes in chronic kidney disease?
    Nephrol Dial Transplant. 2016.
    >> Share

  188. SOOHOO M, Ahmadi SF, Qader H, Streja E, et al
    Association of serum vitamin B12 and folate with mortality in incident hemodialysis patients.
    Nephrol Dial Transplant. 2016.
    >> Share

  189. ARROYO D, Betriu A, Valls J, Gorriz JL, et al
    Factors influencing pathological ankle-brachial index values along the chronic kidney disease spectrum: the NEFRONA study.
    Nephrol Dial Transplant. 2016.
    >> Share

  190. LADHANI M, Craig JC, Irving M, Clayton PA, et al
    Obesity and the risk of cardiovascular and all-cause mortality in chronic kidney disease: a systematic review and meta-analysis.
    Nephrol Dial Transplant. 2016.
    >> Share

  191. AGARWAL R, Georgianos PI
    Con: Nutritional vitamin D replacement in chronic kidney disease and end-stage renal disease.
    Nephrol Dial Transplant. 2016;31:706-13.
    >> Share

  192. ZOCCALI C, Mallamaci F
    Moderator's view: Vitamin D deficiency treatment in advanced chronic kidney disease: a close look at the emperor's clothes.
    Nephrol Dial Transplant. 2016;31:714-6.
    >> Share

  193. GOLDSMITH DJ
    Pro: Should we correct vitamin D deficiency/insufficiency in chronic kidney disease patients with inactive forms of vitamin D or just treat them with active vitamin D forms?
    Nephrol Dial Transplant. 2016;31:698-705.
    >> Share

    April 2016
  194. NG DK, Robertson CC, Woroniecki RP, Limou S, et al
    APOL1-associated glomerular disease among African-American children: a collaboration of the Chronic Kidney Disease in Children (CKiD) and Nephrotic Syndrome Study Network (NEPTUNE) cohorts.
    Nephrol Dial Transplant. 2016.
    >> Share

  195. THOMPSON S, Manns B, Lloyd A, Hemmelgarn B, et al
    Impact of using two dialyzers in parallel on phosphate clearance in hemodialysis patients: a randomized trial.
    Nephrol Dial Transplant. 2016.
    >> Share

  196. FINDLAY MD, Donaldson K, Doyle A, Fox JG, et al
    Factors influencing withdrawal from dialysis: a national registry study.
    Nephrol Dial Transplant. 2016.
    >> Share

  197. CHEUNGPASITPORN W, Thongprayoon C, Gonzalez-Suarez ML, Srivali N, et al
    The effects of short sleep duration on proteinuria and chronic kidney disease: a systematic review and meta-analysis.
    Nephrol Dial Transplant. 2016.
    >> Share

  198. LACHMANN N, Schonemann C, El-Awar N, Everly M, et al
    Dynamics and epitope specificity of anti-human leukocyte antibodies following renal allograft nephrectomy.
    Nephrol Dial Transplant. 2016.
    >> Share

  199. LUTTROPP K, Debowska M, Lukaszuk T, Bobrowski L, et al
    Genotypic and phenotypic predictors of inflammation in patients with chronic kidney disease.
    Nephrol Dial Transplant. 2016.
    >> Share

  200. HANSEN D, Olesen JB, Gislason GH, Abrahamsen B, et al
    Risk of fracture in adults on renal replacement therapy: a Danish national cohort study.
    Nephrol Dial Transplant. 2016.
    >> Share

  201. UNRUH ML, Larive B, Eggers PW, Garg AX, et al
    The effect of frequent hemodialysis on self-reported sleep quality: Frequent Hemodialysis Network Trials.
    Nephrol Dial Transplant. 2016.
    >> Share

  202. HEMMELGARN BR, Pannu N, Ahmed SB, Elliott MJ, et al
    Determining the research priorities for patients with chronic kidney disease not on dialysis.
    Nephrol Dial Transplant. 2016.
    >> Share

  203. GALLE JC, Addison J, Suranyi MG, Claes K, et al
    Outcomes in patients with chronic kidney disease not on dialysis receiving extended dosing regimens of darbepoetin alfa: long-term results of the EXTEND observational cohort study.
    Nephrol Dial Transplant. 2016.
    >> Share

  204. SHEN JI, Saxena AB, Montez-Rath ME, Chang TI, et al
    Angiotensin-converting enzyme inhibitor/angiotensin receptor blocker use and cardiovascular outcomes in patients initiating peritoneal dialysis.
    Nephrol Dial Transplant. 2016.
    >> Share

  205. GOUPIL R, Dupuis D, Agharazii M, Hamet P, et al
    Central blood pressures in early chronic kidney disease: an analysis of CARTaGENE.
    Nephrol Dial Transplant. 2016.
    >> Share

  206. MESSA P
    Skeletal fractures in patients on renal replacement therapy: how large still is the knowledge gap.
    Nephrol Dial Transplant. 2016.
    >> Share

  207. ALLINOVI M, Saleem M, Romagnani P, Nazerian P, et al
    Lung ultrasound: a novel technique for detecting fluid overload in children on dialysis.
    Nephrol Dial Transplant. 2016.
    >> Share

  208. MOISEEV S, Novikov P, Jayne D, Mukhin N, et al
    End-stage renal disease in ANCA-associated vasculitis.
    Nephrol Dial Transplant. 2016.
    >> Share

  209. BERNARDO AA, Marbury TC, McFarlane PA, Pauly RP, et al
    Clinical safety and performance of VIVIA: a novel home hemodialysis system.
    Nephrol Dial Transplant. 2016.
    >> Share

  210. VANHOLDER R, Glorieux G, Massy ZA
    Intestinal metabolites, chronic kidney disease and renal transplantation: Enigma Variations?
    Nephrol Dial Transplant. 2016.
    >> Share

    March 2016
  211. PUELLES VG, Kanzaki G, Bertram JF
    Indirect estimation of nephron number: a new tool to predict outcomes in renal transplantation?
    Nephrol Dial Transplant. 2016.
    >> Share

  212. SCHWAIGER E, Eskandary F, Kozakowski N, Bond G, et al
    Deceased donor kidney transplantation across donor-specific antibody barriers: predictors of antibody-mediated rejection.
    Nephrol Dial Transplant. 2016.
    >> Share

  213. RODERICK PJ, Jeffrey RF, Yuen HM, Godfrey KM, et al
    Smaller kidney size at birth in South Asians: findings from the Born in Bradford birth cohort study.
    Nephrol Dial Transplant. 2016;31:455-65.
    >> Share

  214. NAZZAL L, Puri S, Goldfarb DS
    Enteric hyperoxaluria: an important cause of end-stage kidney disease.
    Nephrol Dial Transplant. 2016;31:375-82.
    >> Share

    February 2016
  215. SEKULA P, Li Y, Stanescu HC, Wuttke M, et al
    Genetic risk variants for membranous nephropathy: extension of and association with other chronic kidney disease aetiologies.
    Nephrol Dial Transplant. 2016.
    >> Share

  216. PINTER J, Hanson CS, Craig JC, Chapman JR, et al
    'I feel stronger and younger all the time'-perspectives of elderly kidney transplant recipients: thematic synthesis of qualitative research.
    Nephrol Dial Transplant. 2016.
    >> Share

  217. WANG IK, Lin CL, Lin PC, Chang SN, et al
    Seasonal influenza vaccination is associated with reduced morbidity and mortality in peritoneal dialysis patients.
    Nephrol Dial Transplant. 2016;31:269-74.
    >> Share

    January 2016
  218. WETMORE JB, Liu J, Do TP, Lowe KA, et al
    Changes in secondary hyperparathyroidism-related biochemical parameters and medication use following parathyroidectomy.
    Nephrol Dial Transplant. 2016;31:103-11.
    >> Share

    August 2015
  219. LOFARO D, Jager KJ, Abu-Hanna A, Groothoff JW, et al
    Identification of subgroups by risk of graft failure after paediatric renal transplantation: application of survival tree models on the ESPN/ERA-EDTA Registry.
    Nephrol Dial Transplant. 2015.
    >> Share

  220. EVANS M, Suttorp MM, Bellocco R, Hoekstra T, et al
    Trends in haemoglobin, erythropoietin-stimulating agents and iron use in Swedish chronic kidney disease patients between 2008 and 2013.
    Nephrol Dial Transplant. 2015.
    >> Share

    November 2014
  221. HOGAN J, Audry B, Harambat J, Dunand O, et al
    Are there good reasons for inequalities in access to renal transplantation in children?
    Nephrol Dial Transplant. 2014.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016